Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why would the deal not be done? He has his 48M shares (now 45M from recent sale). I haven’t seen anything saying it’s closed but curious why it wouldn’t be. Thanks.
That short chart follows our share price exact. This guy is single handedly controlling the price. I thought it was the dilution/conversion causing the push down. Does he not have to report that short activity? Selling 3 million shares alone shouldn’t have that affect. Thanks for the info.
Thoughts on the filing?
Yozma deal is complete. They converted shares to cover some debt, little over $3M. Yozma exercised their right to purchase 17M shares themselves. Their shares are unrestricted but GC has said their intention is to hold those shares long term with NASDAQ as their goal. Yozma has filed that they have no interest in being on the board so all business between the two is complete, they are simply investors.
We SHOULD be trading much higher. Lol. I love how GC hinted last night that todos test is better than an $8B test right before coming out with the patent advancement. Haha. Pretty bold claim.
Does anyone know if the shares created by the convertible notes are restricted or not? Mainly the option buys like Yozma took advantage of. Interesting to know if those 17M shares are restricted for some time or would need to be reported before selling or if they could one day just dump them back into the market.
GC speaks on "The Nation Speaks". Talked about the idea of the 'golden ticket' (vaccine card to travel).
https://www.theepochtimes.com/the-nation-speaks-march-27-vaccine-passport-rabbit-hole-hospitals-slow-walk-new-pricing-rules-the-day-president-reagan-was-shot_3751147.html
Looking like fun today. Lol.
If you want to be the part, you have to look the part. Haha. Just kidding. Who votes the price moves up next week? If it holds to past patterns, next week is going to be very fun.
I agree, a $250M market cap should be the minimum. Hard to evaluate the other ventures without more information where they’re at in research. There’s some info on the Alzheimer’s side being valued over $100M by an outside appraiser. The Covid side would easily be valued at $500M+ if they could show the revenue was more sustainable. Breast and colon cancer testing is the biggest unknown for me. Could add a lot more value.
They are certainly trying to get public attention right now. It has been dilution up to this point but it was also foreseeable dilution. Debt is getting really low at this point and revenue is getting really high. We should see the dilution dry up now and share price move up in those multiples. How many multiples are you targeting?
Here’s their pr update. Answers your question about the relevance of the Wall Street journal article.
https://investor.todosmedical.com/news-events/press-releases/detail/106/todos-medical-provides-corporate-update
Few things coming out. Maybe get some volume from this. Nice info.
https://www.google.com/amp/s/www.proactiveinvestors.com/companies/amp/news/944149
Here is an article the came out today. Some good info here. https://www.stck.pro/news/TOMDF/11631272
(YOZMA $3.4M) "Todos Medical intends to use the money to retire outstanding convertible notes as well as complete the acquisition of Provista Diagnostics for its Videssa breast cancer blood test and its COVID-19 PCR-testing capabilities at its Georgia-based CLIA/CAP certified lab.
The capital injection comes at a time when Todos Medical is also developing blood tests for the early detection of neurodegenerative disorders, such as Alzheimer's disease. One product in the works is called the Lymphocyte Proliferation Test (LymPro Test).
Todos Medical has also formed strategic partnerships with Integrated Health LLC, MOTOPARA Foundation to deploy mobile COVID-19 testing across the United States.
As for contracts, the company recently struck a preferred vendor agreement to supply COVID-19 related testing products and services to Natural Wellness Clinics (NWC) for use in its efforts to test Kentucky's uninsured. NWC just landed a $93 million state contract to conduct the testing. "
Says it was published March 12 but this is the first I’ve been seeing it around. It’s definitely not widely seen yet.
Crickets on this board. Lol. What are your thoughts on the interview? I thought it was good. Laid the groundwork for future revenue and contracts due to the stimulus. Covid testing looks to be a little more long term now with schools and airports so that’s great for funding their own R&D which is the real diamond here.
Guess I should have looked at news first. I didn’t see they released financials. Haha.
Yup, public releases are key at this point. Get the name out. I have no idea why they holding back information at this point. Just pure manipulation in my opinion. They’ll let it go when they are done.
Hahahaha. Hehehehehe. Gotta laugh, right? This was huge! A maybe we’ll get some of this stimulus money? Lol. I know it’ll likely be good for Todos, I’m guessing they have some contracts proposed that depended on more government funding and this big bill is basically a blank check. Ready for some real news we can take to the bank though.
Dear Diary:
It’s been four days and G hasn’t said a word to me. I don’t know what I did. I hope he knows that I’m thinking of him.
Article Gerald tweeted about.
https://stm.sciencemag.org/content/12/557/eabc5332
Geralds PR: How is your hump day going? Day 3. Is it today?
Haha. I like this thread. You’re all good people. I don’t care what Gerald says about you. Lol.
You caught me. I am GC. Lol.
Haha. Please give us a little tickle!
I tend to lean against JP in most matters. Lol. I understand the idea of bringing all info forward, positive and negative, so people know what they own. Information can be hard to find, especially on the OTC. JP clearly has that ax to grind. He doesn’t put any real information forward concerning Todos so his warnings look like “HURRICANE” on a clear blue day. The last time I questioned him just a little, he said he gives up and I’m basically an idiot for questioning him. I enjoy your threads, they have real info and real concerns to consider. That’s what we need.
BTW, I did find your post humorous. Lol. Just curious about your reasons, intent, and what could change your mind.
Is there anything that could change your or JP’s mind or pessimistic speech? What if he does start releasing updates next week? What if they do ramp up revenue even more? What if he doesn’t do any more dilution? What if the price hits $.25? $1? $2? More? What would it take or are your minds made up no matter what? I never invested in AMBS. I still haven’t. I don’t see any real hype there. Todos is generating a lot of revenue and has future opportunities for more. I think it could do really well. I could make a long list of why I think it’s good and my list of bad things gets shorter every day. This is not AMBS. There’s relation between the two but Todos is a different stock.
Nice. Next week starts the fun. Gonna be a good March. Thank you for sharing.
I wished we’d hear something about anything at this point. GC never says anything of substance to anyone on Twitter. A lot of “news coming soon” or “will update soon”. It’s been a long month of silence. Hopefully PR soon.
So no RS or reverse? Can’t tell if the second tweet is referencing a reverse split or if he means just reversing the direction of the stock price to go up.
Hello. Sorry, what deal went stale?
Estimating and connecting dots is all most of us have about publicly traded companies. I’m not warren buffet, I don’t get to see how the business runs it’s everyday operations, I get PRs and Twitter. Since I started following todos, I haven’t seen any bad behavior from GC. It’s all come to fruit from what I can see. Of course I want more transparency and to see the financials, I also believe that info is coming soon. I believe it was you who had brought up their issue with convertible debt a long time ago and wished I had known more about that, wished it was more public. Good call. It’s a different ball game now with incoming revenue and I believe GC was a big part of that. It takes time to clean up old debt. Calling him a scam artist isn’t going to get me to sell my shares. I want to hear both sides of the story but with detail. These threads are the best way for people like me to share ideas and make investment decisions. I do appreciate your intel and your interpretation. What do you see holding back the share price, other than GC belongs in jail?
I understand the two are different. My posts kept them separate and named one as an offering and the other as convertible. Nothing has been made public stating they are done, I’ve made sure to use verbiage like “looks like” and “in my opinion”. I’ve been following this stock closely for over a year, invested in it for about 7 months. Doing the math, it “looks” like the dilution from the offering ended in December around 396M OS. Doing the math, it looks like the convertible debt with Yozma should be close to done or done at current OS around 483M.
From Todos investor's page on website. It looks like this finally ended in December, 2020.
REHOVOT, Israel, July 11, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics company focused on the development of blood tests for the early detection of cancer and neurodegenerative disorders, such as Alzheimer's disease, today announced that it has launched a roadshow for a public offering of up to $7,000,000 of units. Each unit issued in the offering will consist of one share of common stock and one warrant to purchase one share of common stock. The common stock and warrants will be immediately separable from the units and will be issued separately.
A year ago, Todos was an R&D lab with no revenue, only expense. They pay for that with dilution. Most of that was an offering that started in, I believe, July 2019 to raise about $7M. That finally ended so now they are cleaning up convertible debt which I believe should be about done if not already done. Company is now cash flow positive, paying for their own R&D so lowers risk for investors substantially in my opinion.
That’s about $4.3-$4.5M since yozma deal was made. Does that mean conversion is over and we can start moving up? If we see a pr tomorrow, I’ll take that as a yes. Lol.
Very quiet. Guessing they are waiting for Yozma to finish the note before all of the announcements, don’t want them to artificially hold the price down. Looking forward to January numbers, $6M+, 2020 financials, 2021 projections, Brooklyn and mobile updates, new or increased contracts. And that’s just Covid testing. Lol. Lots in the pipeline.
Does yozma get shares now? I didn’t think anything happened with shares for a year. Trying to understand. Thanks in advance.